Carbogen Amcis has revealed that its Shanghai facility has obtained its first Drug Manufacturing License from China’s ...

Carbogen Amcis’ Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s NMPA.

The first quarter of 2025 will be remembered for rapid change. U.S. presidential transitions typically focus on achieving one ...

India is planning to ease its nuclear liability laws by capping accident-related penalties for equipment suppliers, in an ...

US-based PharmaLogic Holdings Corp, a contract development and manufacturing organisation (CDMO) specialising in ...

Pacific Fusion made a splash in October when it emerged from stealth with a $900 million Series A and a founding team led by ...

Pharma stocks such as Sun Pharma, Aurobindo Pharma, Dr Reddy's Lab, Cipla, Gland Pharma, Zydus Lifesciences and Lupin would be in action on Friday after the US President Donald Trump halted ...

Most of the pharma bigwigs ended the trading session in green after bearing the brunt of investors’ skepticism earlier in the day on a plausible import tariff. Last week, Trump announced new ...

Still, he said that they were expecting Trump’s policy to impact the global supply chain, especially for U.S.-based pharma companies that have shifted their production to other regions.

"Given the complexity of the pharma supply chain, we do not expect the industry to make any major changes. These current tariffs are being pursued under emergency powers, which at worse will last ...

Analysts believe the key question is whether India can be exempted from the pharma tariffs, given the better relationship between the countries and the critical nature of India’s generic drug ...

Donald Trump pauses his "reciprocal" tariffs for 90 days. Dow Jones pharma stocks reverse higher on tariff pause. Trump raises his tariffs on Chinese goods to 125%. MRK, AMGN and JNJ all recover ...